Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01263600 · ClinicalTrials.gov registry record

Hepatitis B Research Network Pediatric Cohort Study (HBRN)

A clinical trial, sponsored by University of Pittsburgh.

Completed
Registry status
462
Enrollment target

NCT01263600 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 462 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01263600 has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
462 participants
Enrollment target

Study Summary

The purpose of this study is to describe participants 6 months to \<18 years of age with hepatitis B virus (HBV) infection in a prospective cohort in the United States (US) and Canada and identify predictors of disease activation and progression.

Trial Details

FieldValue
Enrollment Target 462 participants
Start Date 2010-12
Est. Completion 2021-06-09

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT01263600

The ClinicalTrials.gov registry entry for NCT01263600 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 462 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01263600 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01263600 about?

NCT01263600 is a clinical study titled "Hepatitis B Research Network Pediatric Cohort Study (HBRN)". The purpose of this study is to describe participants 6 months to \<18 years of age with hepatitis B virus (HBV) infection in a prospective cohort in the United States (US) and Canada and identify predictors of disease activation and progression.

What is the current status of trial NCT01263600?

This trial is currently completed. The enrollment target is 462 participants. The study started on 2010-12. Estimated completion is 2021-06-09.

Who is sponsoring clinical trial NCT01263600?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.